The European Medicines Agency Approval of Axitinib (Inlyta) for the Treatment of Advanced Renal Cell Carcinoma After Failure of Prior TreatmentWith Sunitinib or a Cytokine: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Saved in:
Bibliographic Details
Published in:The oncologist (Dayton, Ohio) Ohio), 2015-02, Vol.20 (2), p.196
Main Authors: Tzogani, K, Skibeli, V, Westgaard, I, Dalhus, M, Thoresen, H, Slot, KB, Damkier, P, Hofland, K, Borregaard, J, Ersboll, J
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-7159
DOI:10.1634/theoncologist.2014-0177